The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs

Jarir Atthobari; T.B.M. Monster; P.E. de Jong; Lolkje Theodora Wilhelmina de Jong-van den Berg; PREVEND Study Group

doi:10.1046/j.1365-2125.2003.02011.x

The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs

Jarir Atthobari, T.B.M. Monster, P.E. de Jong, Lolkje Theodora Wilhelmina de Jong-van den Berg^*, PREVEND Study Group

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput › Academic › peer review

17 Citaten (Scopus)

Originele taal-2	English
Pagina's (van-tot)	328-336
Aantal pagina's	9
Tijdschrift	British Journal of Clinical Pharmacology
Volume	57
Nummer van het tijdschrift	3
DOI's	https://doi.org/10.1046/j.1365-2125.2003.02011.x
Status	Published - 2004

Toegang tot document

10.1046/j.1365-2125.2003.02011.x

Handle.net

Permanente koppeling

Document onder embargo

The effect of hypertension and hypercholesterolemia screening with subsequent
Final publisher's version, 157 KB
Kopie aanvragen

Citeer dit

Atthobari, J., Monster, T. B. M., de Jong, P. E., de Jong-van den Berg, L. T. W., & PREVEND Study Group (2004). The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs. British Journal of Clinical Pharmacology, 57(3), 328-336. https://doi.org/10.1046/j.1365-2125.2003.02011.x

@article{5fcf515072b2486c96dd7d95f9261f8d,

title = "The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs",

keywords = "blood pressure lowering drug, general practitioner, hyperlipidemia, hypertension, incidence, intervention, letter, lipid lowering drug, patient, population screening, predictor variable, prevalence, URINARY ALBUMIN EXCRETION, CORONARY HEART-DISEASE, NONDIABETIC POPULATION, GENERAL-PRACTITIONERS, PRESCRIBING BEHAVIOR, POSTAL PROMPTS, RISK-FACTORS, MANAGEMENT, GUIDELINES, STROKE",

author = "Jarir Atthobari and T.B.M. Monster and {de Jong}, P.E. and {de Jong-van den Berg}, {Lolkje Theodora Wilhelmina} and {PREVEND Study Group}",

note = "J Article",

year = "2004",

doi = "10.1046/j.1365-2125.2003.02011.x",

language = "English",

volume = "57",

pages = "328--336",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley",

number = "3",

}

Atthobari, J, Monster, TBM, de Jong, PE, de Jong-van den Berg, LTW & PREVEND Study Group 2004, 'The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs', British Journal of Clinical Pharmacology, vol. 57, nr. 3, blz. 328-336. https://doi.org/10.1046/j.1365-2125.2003.02011.x

TY - JOUR

T1 - The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs

AU - Atthobari, Jarir

AU - Monster, T.B.M.

AU - de Jong, P.E.

AU - de Jong-van den Berg, Lolkje Theodora Wilhelmina

AU - PREVEND Study Group

N1 - J Article

PY - 2004

Y1 - 2004

KW - blood pressure lowering drug

KW - general practitioner

KW - hyperlipidemia

KW - hypertension

KW - incidence

KW - intervention

KW - letter

KW - lipid lowering drug

KW - patient

KW - population screening

KW - predictor variable

KW - prevalence

KW - URINARY ALBUMIN EXCRETION

KW - CORONARY HEART-DISEASE

KW - NONDIABETIC POPULATION

KW - GENERAL-PRACTITIONERS

KW - PRESCRIBING BEHAVIOR

KW - POSTAL PROMPTS

KW - RISK-FACTORS

KW - MANAGEMENT

KW - GUIDELINES

KW - STROKE

U2 - 10.1046/j.1365-2125.2003.02011.x

DO - 10.1046/j.1365-2125.2003.02011.x

M3 - Article

SN - 0306-5251

VL - 57

SP - 328

EP - 336

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 3

ER -